Capital Research Global Investors - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q3 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.

Quarter-by-quarter ownership
Capital Research Global Investors ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$593,301,598
+4.2%
6,623,148
-1.0%
0.16%
+6.5%
Q2 2023$569,547,350
+3.4%
6,689,539
+0.5%
0.15%
-2.5%
Q1 2023$550,597,151
+17.5%
6,653,742
+11.7%
0.16%
+10.6%
Q4 2022$468,444,434
+0.7%
5,956,064
-5.3%
0.14%
-7.2%
Q3 2022$465,373,000
+13.7%
6,286,276
+0.1%
0.15%
+19.5%
Q2 2022$409,424,000
+18.8%
6,281,436
+15.2%
0.13%
+50.6%
Q1 2022$344,676,000
+217.1%
5,452,006
+166.1%
0.08%
+254.2%
Q4 2021$108,686,000
+35.8%
2,049,133
+80.7%
0.02%
+26.3%
Q3 2021$80,031,000
-55.2%
1,133,748
-57.7%
0.02%
-54.8%
Q2 2021$178,551,000
-74.1%
2,679,336
-56.9%
0.04%
-75.1%
Q1 2021$690,204,000
+3.1%
6,217,498
+10.3%
0.17%
-2.9%
Q4 2020$669,481,000
+59.0%
5,637,735
+16.8%
0.17%
+38.1%
Q3 2020$421,026,000
+17.9%
4,825,515
+21.0%
0.13%
+11.5%
Q2 2020$357,166,000
+23.8%
3,988,003
+37.8%
0.11%0.0%
Q1 2020$288,396,000
-6.9%
2,893,800
+7.4%
0.11%
+21.5%
Q4 2019$309,633,000
-3.8%
2,694,800
+5.6%
0.09%
-12.3%
Q3 2019$321,783,000
+4.8%
2,551,0000.0%0.11%
+9.3%
Q2 2019$306,987,000
+148.5%
2,551,000
+80.6%
0.10%
+148.7%
Q1 2019$123,535,000
-12.6%
1,412,1500.0%0.04%
-20.4%
Q4 2018$141,286,000
-24.1%
1,412,150
-13.0%
0.05%
-9.3%
Q3 2018$186,078,000
+27.8%
1,624,0000.0%0.05%
+35.0%
Q2 2018$145,640,000
+62.6%
1,624,000
+32.7%
0.04%
+60.0%
Q1 2018$89,548,000
+336.2%
1,224,000
+246.3%
0.02%
+316.7%
Q4 2017$20,529,000353,4590.01%
Other shareholders
HAEMONETICS CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Iron Triangle Partners LP 330,000$36,633,0004.66%
BEACONLIGHT CAPITAL, LLC 156,395$17,361,0002.80%
Bridge City Capital, LLC 48,011$5,330,0001.77%
Summit Creek Advisors LLC 121,362$13,472,0001.61%
Sivik Global Healthcare LLC 25,000$2,775,0001.01%
ANCHOR CAPITAL ADVISORS LLC 412,218$45,760,0000.97%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 69,655$7,732,0000.90%
Orbimed Advisors 852,000$94,581,0000.88%
LONDON CO OF VIRGINIA 1,057,738$117,420,0000.67%
WEXFORD CAPITAL LP 40,138$4,456,0000.66%
View complete list of HAEMONETICS CORP shareholders